Loading...
XSHG
603139
Market cap286mUSD
Jun 09, Last price  
20.62CNY
1D
3.05%
1Q
33.03%
IPO
-10.66%
Name

Shaanxi Kanghui Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
P/E
—
P/S
3.06
EPS
—
Div Yield, %
—
Shrs. gr., 5y
0.25%
Rev. gr., 5y
12.37%
Revenues
673m
+36.92%
276,820,956328,064,455375,731,468379,785,070381,845,771367,057,156375,618,264431,421,291414,071,702442,756,905491,511,206672,960,241
Net income
-26m
40,398,48855,822,17662,741,93862,205,19365,234,11263,019,58655,629,18142,763,04234,113,73036,481,4660-26,158,640
CFO
0k
-100.00%
16,119,75639,351,30022,724,63728,502,79671,718,35743,597,45862,635,269107,525,83993,722,9697,418,78850,434,2000
Dividend
Jun 29, 20220.074 CNY/sh

Profile

Shaanxi Kanghui Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. It offers gynecological, orthopedic, dermatology, diabetes, respiratory system, urinary system, cardiovascular and cerebrovascular, gastrointestinal, hepatobiliary, and other drugs in the form of tablets, capsules, granules, mixtures, teas, plasters, ointments, liniments, lotions, and tinctures. The company is based in Xianyang, China.
URL
http://www.sxkh.com/
IPO date
Apr 21, 2017
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
672,960
36.92%
491,511
11.01%
Cost of revenue
646,749
451,689
Unusual Expense (Income)
NOPBT
26,212
39,823
NOPBT Margin
3.89%
8.10%
Operating Taxes
(7,168)
Tax Rate
NOPAT
33,380
39,823
Net income
(26,159)
 
Dividends
(7,391)
Dividend yield
0.42%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
200,559
145,352
Long-term debt
285,705
387,223
Deferred revenue
35,247
36,013
Other long-term liabilities
755
879
Net debt
228,036
186,191
Cash flow
Cash from operating activities
50,434
CAPEX
(72,381)
Cash from investing activities
(45,965)
Cash from financing activities
54,646
7,591
FCF
79,247
(97,859)
Balance
Cash
166,774
230,774
Long term investments
91,454
115,609
Excess cash
224,580
321,808
Stockholders' equity
609,433
615,457
Invested Capital
1,315,779
1,264,853
ROIC
2.59%
3.16%
ROCE
1.70%
2.49%
EV
Common stock shares outstanding
100,610
99,880
Price
18.77
5.75%
17.75
-18.47%
Market cap
1,888,453
6.52%
1,772,870
-18.47%
EV
2,187,176
2,011,279
EBITDA
63,924
65,166
EV/EBITDA
34.22
30.86
Interest
23,461
13,218
Interest/NOPBT
89.51%
33.19%